Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
- PMID: 36826829
- PMCID: PMC9958521
- DOI: 10.1001/jamahealthforum.2022.5610
Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
Plain language summary
This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.
Conflict of interest statement
Figures
References
-
- American Medical Association . 2019. AMA Prior Authorization (PA) Physician Survey. Accessed June 24, 2020. https://www.ama-assn.org/system/files/2020-06/prior-authorization-survey...
-
- Cubanski J, Damico A, Neuman T. 10 Things to Know About Medicare Part D Coverage and Costs in 2019. Kaiser Family Foundation; 2019. Accessed December 1, 2022. www.kff.org/medicare/issue-brief/10-things-to-know-about-medicare-part-d...
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
